Pavlína Hašková

942 total citations
28 papers, 803 citations indexed

About

Pavlína Hašková is a scholar working on Nutrition and Dietetics, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Pavlína Hašková has authored 28 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nutrition and Dietetics, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Pavlína Hašková's work include Trace Elements in Health (12 papers), Iron Metabolism and Disorders (6 papers) and Cardiac Ischemia and Reperfusion (6 papers). Pavlína Hašková is often cited by papers focused on Trace Elements in Health (12 papers), Iron Metabolism and Disorders (6 papers) and Cardiac Ischemia and Reperfusion (6 papers). Pavlína Hašková collaborates with scholars based in Czechia, Australia and United States. Pavlína Hašková's co-authors include Tomáš Šimůnek, Anna Vávrová, Petra Kovařı́ková, Kateřina Vávrová, Martin Štěrba, Hana Jansová, Olga Popelová, Miloslav Macháček, Vladimír Geršl and Miroslav Červinka and has published in prestigious journals such as PLoS ONE, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Pavlína Hašková

28 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pavlína Hašková Czechia 18 223 197 193 164 151 28 803
Anna Vávrová Czechia 11 223 1.0× 320 1.6× 208 1.1× 83 0.5× 96 0.6× 15 689
Joan L. Buss Canada 18 288 1.3× 87 0.4× 319 1.7× 204 1.2× 170 1.1× 22 1.1k
Yong-Ri Jin South Korea 24 164 0.7× 134 0.7× 687 3.6× 40 0.2× 149 1.0× 42 1.3k
Olga Popelová Czechia 17 455 2.0× 1.0k 5.1× 396 2.1× 132 0.8× 112 0.7× 25 1.6k
Molly Gallogly United States 12 121 0.5× 70 0.4× 1.0k 5.4× 129 0.8× 54 0.4× 40 1.5k
Y Mazurová Czechia 18 181 0.8× 489 2.5× 162 0.8× 55 0.3× 48 0.3× 48 789
Dan Gelvan Israel 11 43 0.2× 74 0.4× 158 0.8× 87 0.5× 58 0.4× 17 536
Vladimír Geršl Czechia 22 545 2.4× 1.3k 6.7× 476 2.5× 190 1.2× 136 0.9× 52 2.0k
Dan Su China 23 95 0.4× 32 0.2× 673 3.5× 506 3.1× 54 0.4× 56 1.3k
Cai Li China 18 386 1.7× 26 0.1× 475 2.5× 100 0.6× 154 1.0× 61 1.4k

Countries citing papers authored by Pavlína Hašková

Since Specialization
Citations

This map shows the geographic impact of Pavlína Hašková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavlína Hašková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavlína Hašková more than expected).

Fields of papers citing papers by Pavlína Hašková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavlína Hašková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavlína Hašková. The network helps show where Pavlína Hašková may publish in the future.

Co-authorship network of co-authors of Pavlína Hašková

This figure shows the co-authorship network connecting the top 25 collaborators of Pavlína Hašková. A scholar is included among the top collaborators of Pavlína Hašková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavlína Hašková. Pavlína Hašková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hašková, Pavlína, Lenka Applová, Hana Jansová, et al.. (2022). Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine. Scientific Reports. 12(1). 9765–9765. 7 indexed citations
2.
Jansová, Hana, Jan Bureš, Miloslav Macháček, et al.. (2016). Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products. Toxicology. 350-352. 15–24. 14 indexed citations
3.
Hašková, Pavlína, Hana Jansová, Jan Bureš, et al.. (2016). Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury. Toxicology. 371. 17–28. 16 indexed citations
4.
Potůčková, Eliška, et al.. (2016). Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modifications. European Journal of Medicinal Chemistry. 120. 97–110. 40 indexed citations
5.
Potůčková, Eliška, Jaroslav Roh, Miloslav Macháček, et al.. (2015). In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites. PLoS ONE. 10(10). e0139929–e0139929. 8 indexed citations
6.
Potůčková, Eliška, Hana Jansová, Miloslav Macháček, et al.. (2014). Quantitative Analysis of the Anti-Proliferative Activity of Combinations of Selected Iron-Chelating Agents and Clinically Used Anti-Neoplastic Drugs. PLoS ONE. 9(2). e88754–e88754. 26 indexed citations
7.
Potůčková, Eliška, Jan Bureš, Petra Kovařı́ková, et al.. (2014). Structure-Activity Relationships of Novel Salicylaldehyde Isonicotinoyl Hydrazone (SIH) Analogs: Iron Chelation, Anti-Oxidant and Cytotoxic Properties. PLoS ONE. 9(11). e112059–e112059. 17 indexed citations
8.
Jansová, Hana, Miloslav Macháček, Qin Wang, et al.. (2014). Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury. Free Radical Biology and Medicine. 74. 210–221. 30 indexed citations
9.
Vávrová, Anna, Hana Jansová, Miloslav Macháček, et al.. (2013). Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells. PLoS ONE. 8(10). e76676–e76676. 59 indexed citations
10.
Vávrová, Anna, Hana Jansová, Pavlína Hašková, et al.. (2012). Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: Novel iron chelators with selective antiproliferative action. Chemico-Biological Interactions. 197(2-3). 69–79. 43 indexed citations
11.
Jirkovský, Eduard, Olga Popelová, Anna Vávrová, et al.. (2012). Chronic Anthracycline Cardiotoxicity: Molecular and Functional Analysis with Focus on Nuclear Factor Erythroid 2-Related Factor 2 and Mitochondrial Biogenesis Pathways. Journal of Pharmacology and Experimental Therapeutics. 343(2). 468–478. 48 indexed citations
12.
Kovařı́ková, Petra, et al.. (2011). Synthesis and Initial in Vitro Evaluations of Novel Antioxidant Aroylhydrazone Iron Chelators with Increased Stability against Plasma Hydrolysis. Chemical Research in Toxicology. 24(3). 290–302. 49 indexed citations
13.
14.
Hašková, Pavlína, et al.. (2010). Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity. Free Radical Biology and Medicine. 50(4). 537–549. 41 indexed citations
15.
Hašková, Pavlína, et al.. (2010). Effect of phytic acid and inositol on the proliferation and apoptosis of cells derived from colorectal carcinoma.. PubMed. 23(3). 787–93. 29 indexed citations
16.
Vávrová, Anna, Olga Popelová, Martin Štěrba, et al.. (2010). In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity. Archives of Toxicology. 85(5). 525–535. 21 indexed citations
17.
Popelová, Olga, Martin Štěrba, Pavlína Hašková, et al.. (2009). Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death. British Journal of Cancer. 101(5). 792–802. 52 indexed citations
18.
Mladěnka, Přemysl, Libuše Zatloukalová, Tomáš Šimůnek, et al.. (2008). Direct administration of rutin does not protect against catecholamine cardiotoxicity. Toxicology. 255(1-2). 25–32. 14 indexed citations
19.
Šimůnek, Tomáš, Martin Štěrba, Olga Popelová, et al.. (2008). Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone. British Journal of Pharmacology. 155(1). 138–148. 41 indexed citations
20.
Kovařı́ková, Petra, et al.. (2007). HPLC-DAD and MS/MS analysis of novel drug candidates from the group of aromatic hydrazones revealing the presence of geometric isomers. Journal of Pharmaceutical and Biomedical Analysis. 48(2). 295–302. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Vávrová Breakdown of academic impact, for papers by Joan L. Buss Breakdown of academic impact, for papers by Yong-Ri Jin Breakdown of academic impact, for papers by Olga Popelová Breakdown of academic impact, for papers by Molly Gallogly Breakdown of academic impact, for papers by Y Mazurová Breakdown of academic impact, for papers by Dan Gelvan Breakdown of academic impact, for papers by Vladimír Geršl Breakdown of academic impact, for papers by Dan Su Breakdown of academic impact, for papers by Cai Li
Rankless by CCL
2026